Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases-Reference-Cited by-同舟云学术

Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases

Published:2016-06-09 Issue:12 Volume:10 Page:1385-1394
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:ECCOJC

Author:

Torres Joana,Caprioli Flavio,Katsanos Konstantinos H.,Lobatón Triana,Micic Dejan,Zerôncio Marco,Van Assche Gert,Lee James C.,Lindsay James O.,Rubin David T.,Panaccione Remo,Colombel Jean-Frédéric

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/10/12/1385/8499541/jjw116.pdf

Reference122 articles.

1. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

2. Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3years for adalimumab-treated patients with early Crohn's disease

3. Increased Response and Remission Rates in Short-Duration Crohn's Disease With Subcutaneous Certolizumab Pegol: An Analysis of PRECiSE 2 Randomized Maintenance Trial Data

4. Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

5. Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of artificial intelligence in Crohn's disease intestinal strictures and fibrosis;Journal of Digestive Diseases;2024-08-27

2. Terápiás kihívások nehezen kezelhető, penetráló Crohn-betegségben – multidiszciplináris megoldás;Orvosi Hetilap;2024-08-11

3. The utility of capsule endoscopy in the phenotype of Crohn’s disease. Data from England 2016–2021;Arab Journal of Gastroenterology;2024-08

4. Small bowel Crohn's disease: Proximal lesions linked to increased inflammation and biologic treatment needs;Gastroenterología y Hepatología;2024-08

5. How close are we to a success stratification tool for improving biological therapy in ulcerative colitis?;Expert Opinion on Biological Therapy;2024-06-02